TECAR Therapy: A Clinical Commentary on its Evolution, Application, and Future in Rehabilitation.

Background: TECAR (Transfer of Energy Capacitive and Resistive) therapy is a novel electrotherapy modality gaining traction in orthopedic and sports rehabilitation. This technique utilizes radiofrequency energy to promote tissue healing, pain management, and functional recovery, offering a unique approach to address musculoskeletal injuries and conditions. Purpose: The purpose of this clinical commentary is to delve into the current body of literature on TECAR therapy, meticulously examining both its strengths and the gaps that remain. Methods: A comprehensive literature review was conducted, focusing on the evolving role of TECAR therapy in managing various orthopedic and sports-related injuries. Key studies, including randomized controlled trials and meta-analyses, were evaluated to assess the effectiveness of TECAR therapy in pain reduction, tissue repair, and enhancement of athletic performance. Results: Current evidence suggests that TECAR therapy may effectively reduce pain, improve range of motion, and facilitate tissue regeneration. Notably, it has shown promise in treating conditions such as tendonitis, ligament sprains, and spasticity in stroke survivors. Furthermore, studies indicate that TECAR therapy can enhance biomechanical parameters and running economy, potentially leading to improved athletic performance. Limitations in the current research such as small sample sizes, lack of long-term efficacy studies, and variability in treatment protocols hinder definitive conclusions regarding its clinical utility. Discussion: The authors suggest that integration of TECAR therapy into rehabilitation programs presents opportunities for optimizing patient outcomes and enhancing athletic performance. By incorporating TECAR, athletes may experience faster recovery times, reduced injury risk, and improved performance metrics, making it a potentially valuable addition to sports rehabilitation strategies. Future research should focus on standardizing treatment protocols, exploring long-term effects, and assessing cost-effectiveness to enhance accessibility and implementation in diverse clinical settings. Additionally, mechanistic studies are essential for elucidating the underlying biological processes that contribute to TECAR's therapeutic effects. Conclusion: TECAR therapy represents a promising yet underexplored modality in rehabilitation. As evidence accumulates, its integration into standard clinical practice could revolutionize approaches to pain management and recovery in patients, especially athletes. Continued exploration and validation of TECAR therapy will advance the field of sports physical therapy, unlocking new possibilities for enhancing rehabilitation outcomes and athletic performance. Level of Evidence: 5.